ArticleCureus2025
Post-acute Myocardial Infarction Complication: A Ventricular Septal Defect.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A ventricular septal defect (VSD) is usually a congenital cardiac condition. In the elderly, although it may be present from birth, VSD can be acquired and manifest as a complication of acute myocardial infarction (AMI), as endocarditis, or as a result of cardiac procedures. It can lead to heart failure and other severe consequences demanding medical intervention. This case study describes an 80-year-old obese woman who was diagnosed with inferolateral myocardial infarction with right ventricular (RV) involvement after being admitted with symptoms of acute coronary syndrome (ACS). VSD, a rare mechanical complication, was identified as a contributing factor to hemodynamic instability. The patient underwent percutaneous coronary intervention (PCI) to revascularize the occluded right coronary artery (RCA). Hemodynamic support with norepinephrine and levosimendan, along with mechanical ventilation, was crucial for stabilization. Transfer to a tertiary care facility with cutting-edge surgical skills was essential. This example emphasizes how challenging it can be to manage AMI in elderly people, particularly when unusual side effects like VSD occur. It also highlights how important a multidisciplinary approach is to improving outcomes and optimizing care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.